| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17.06. | Glenmark Pharma arm launches generic Methylene Blue Injection in US market | 3 | capitalmarket.com | ||
| 11.06. | Glenmark Pharmaceuticals launches Winlevi across key European markets | 2 | capitalmarket.com | ||
| 11.06. | Cosmo Pharmaceuticals N.V.: Cosmo Welcomes the Launch of Winlevi(R) in Key European Markets by Its Partner Glenmark | 561 | Newsfile | Dublin, Ireland--(Newsfile Corp. - June 11, 2026) - Cosmo N.V. (SIX: COPN) (XETRA: C43) ("Cosmo") is pleased to make known that its commercial partner Glenmark Specialty S.A (GSSA), a wholly-owned... ► Artikel lesen | |
| 10.06. | Stock Alert: KRN Heat, Patanjali Foods, Bharti Airtel, Dixon Tech, Glenmark Pharma, Bharti Hexacom | 3 | capitalmarket.com | ||
| GLENMARK PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 05.06. | Glenmark Pharma launches generic Lacosamide injection in US | 2 | capitalmarket.com | ||
| 02.06. | Klage gegen Glenmark: Lieferengpässe: Kein Schadenersatz für DAK | 4 | APOTHEKE ADHOC | ||
| 01.06. | Stocks to Watch Today (June 01, 2026): IndiGo, Glenmark Pharma, IREDA, NMDC, Jubilant Pharmova, Cyient and more | 2 | ZEE Business | ||
| 01.06. | Stock Alert: RPP Infra Projects, Indigo, NMDC, GRM Overseas, Glenmark Pharma, NOCIL | 2 | capitalmarket.com | ||
| 30.05. | Glenmark Pharma posts robust Q4 performance | 3 | capitalmarket.com | ||
| 20.05. | IGI, Inc.: Ichnos Glenmark Innovation (IGI) Announces New Development Candidate, ISB 2301, a First-in-Class Multispecific Immune Cells Activator Targeting Solid Tumors | 388 | GlobeNewswire (Europe) | Next-generation multispecific antibody, ISB 2301, targets 3 tumor-associated antigens (TAAs) and activates both T cells and natural killer (NK) cells
IGI's clinically validated BEAT platform enabled... ► Artikel lesen | |
| 18.05. | Glenmark Launches Vancomycin Injection In US, Targets Rs 37.9 Million Market | 2 | The Free Press Journal | ||
| 12.05. | Glenmark Pharmaceuticals Ltd slips for fifth straight session | 2 | capitalmarket.com | ||
| 23.04. | Glenmark Pharmaceuticals Ltd spurts 3.28% | 2 | capitalmarket.com | ||
| 09.04. | Glenmark Gets FDA Approval for Bioequivalent Progesterone Vaginal Insert | 6 | Contract Pharma | ||
| 09.04. | Glenmark Pharmaceuticals Receives U.S. FDA Approval for Progesterone Vaginal Inserts, 100 mg | 931 | PR Newswire | ELMWOOD PARK, N.J., April 9, 2026 /PRNewswire/ -- Glenmark Pharmaceuticals Limited (Glenmark) has received final approval from the United States Food & Drug Administration... ► Artikel lesen | |
| 09.04. | Glenmark Pharma gets USFDA nod for Progesterone Vaginal Inserts | 5 | capitalmarket.com | ||
| 02.04. | Glenmark goes direct with new US Ryaltris marketing plan as it drops partner model | 5 | FiercePharma | ||
| 01.04. | Glenmark Pharmaceuticals Announces Strategic Shift to Direct Commercialization and Distribution of RYALTRIS in the U.S., Significantly Expanding Its Innovative Portfolio | 201 | PR Newswire | RYALTRIS® is Glenmark's first innovative product introduced into the U.S. market
ELMWOOD PARK, N.J., April 1, 2026 /PRNewswire/ -- Glenmark Pharmaceuticals Inc.... ► Artikel lesen | |
| 31.03. | Glenmark Pharmaceuticals Canada Inc. Launches Men's GLN-Minoxidil 5% w/w Topical Aerosol Foam in Canadian Retail | 417 | PR Newswire | GLN-Minoxidil Men's 5% Foam is a topical treatment formulated with 5% minoxidil, a widely used and clinically established ingredient for supporting hair regrowth in men. The fast-drying, unscented aerosol... ► Artikel lesen | |
| 24.03. | Glenmark Pharma may outperform amid market correction; technicals turn positive: Ruchit Jain | 4 | Times of India |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SINOPHARM | 1,830 | +3,98 % | Dividendenbekanntmachungen (23.06.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADAMAS TRUST INC US6496048405 0,27 USD 0,2362 EUR AECON GROUP INC CA00762V1094 0,1925 CAD 0,1189 EUR AMPHENOL CORPORATION US0320951017 0... ► Artikel lesen | |
| CSPC PHARMA | 0,817 | +9,68 % | Dividendenbekanntmachungen (24.06.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AH REALTY TRUST INC US04208T1088 0,14 USD 0,1229 EUR AMBEV SA ADR US02319V1035 0,0091 USD 0,008 EUR ARLANDASTAD GROUP AB SE0016276851 1... ► Artikel lesen | |
| WUXI BIOLOGICS | 3,995 | +8,41 % | WUXI BIO, WUXI APPTEC Jump Up ~6%, 9%; Citi Says CN Healthcare Sector Valuations Attractive with Good Entry Point | ||
| GEDEON RICHTER | 34,380 | +1,24 % | Gedeon Richter Plc.: Extraordinary Information | ||
| SHANGHAI FOSUN PHARMACEUTICAL | 1,797 | +7,22 % | FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE APPROVAL FOR DRUG REGISTRATION OF A SUBSIDIARY | ||
| DR REDDYS | 12,900 | -3,01 % | Dr Reddy's Laboratories gains for sixth straight session | ||
| ASPEN PHARMACARE | 8,250 | 0,00 % | ASPEN PHARMACARE HOLDINGS LIMITED - Dealing in Securities by a Prescribed Officer | ||
| SHANGHAI PHARMACEUTICALS | 1,330 | +3,10 % | SH PHARMA (02607): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | ||
| LUYE PHARMA | 0,208 | +5,58 % | LUYE PHARMA (02186): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 26 JUNE 2026 | ||
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,092 | +7,02 % | SIHUAN PHARM (00460): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 26 JUNE 2026 | ||
| CHINA RESOURCES PHARMACEUTICAL | 0,510 | +4,51 % | CHINARES PHARMA Completes Issuance of RMB2B Corporate Bonds | ||
| HANSOH PHARMACEUTICAL | 3,326 | +3,87 % | HANSOH PHARMA (03692): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON FRIDAY, JUNE 26, 2026 | ||
| CHINA SHINEWAY PHARMACEUTICAL GROUP | 0,815 | +1,88 % | SHINEWAY PHARM (02877): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 28 MAY 2026 | ||
| KALBE FARMA | 0,047 | +40,30 % | Dividendenbekanntmachungen (04.06.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A-LIVING SMART CITY SERVICES CO LTD CNE100002RY5 0,0688 HKD 0,0075 EUR ADESSO SE DE000A0Z23Q5 - 0,78 EUR AGEAS SA/NV ADR US00844W2089 2... ► Artikel lesen | |
| BAYER | 46,030 | -2,06 % | Krebs bleibt die heißeste Wette im Pharmamarkt: Bayer, Vidac Pharma und Pfizer kämpfen um die nächste Therapiegeneration | Der Onkologie-Markt ist der heißeste Bereich der Pharmaindustrie. Während globale Schwergewichte ihre milliardenschweren Pipelines in Stellung bringen, setzt ein kleines Biotech auf einen wissenschaftlichen... ► Artikel lesen |